LINE-1 as a therapeutic target for castration-resistant prostate cancer. [electronic resource]
Producer: 20180601Description: 1292-1309 p. digitalISSN:- 2768-6698
- Alkynes
- Benzoxazines -- therapeutic use
- Clinical Trials, Phase II as Topic
- Cyclopropanes
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Long Interspersed Nucleotide Elements -- genetics
- Male
- Prostatic Neoplasms, Castration-Resistant -- drug therapy
- Reverse Transcriptase Inhibitors -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.